Skip to Content

Posts tagged with "The Dark Side"

  • The Dark Side

    How Many Doctored Papers Are Out There?

    Just how much crap is out there in the scientific literature? “Quite a bit” comes the answer from anyone with real experience of it, but that’s not too quantitative. Here, though is an analysis of one (perfectly respectable) journal of its own output, and the results are. . .well, they range from “pretty bad” to… Read More
  • Business and Markets

    Welcome to Right to Try

    Update: Brainstorm has now abandoned their Right-to-Try approach. Who’s next? That didn’t take long. That didn’t take long at all. The federal “Right to Try” bill was just signed the other week, and we already have a company that’s willing – no, eager – to try it out. I will now cruelly caricature som… Read More
  • General Scientific News

    Science Reform in China

    There have been all sorts of scientific scandals involving faked journal articles, faked peer reviews, duplicated papers and figures, etc. over the last few years. It’s been a running battle: our current technologies allow for these things to be done more easily, but caught more easily as well. And a pretty significant share of these… Read More
  • Snake Oil

    A New Low for Dr. Oz

    Pardon me this morning while I rant a little. In fact, it’s worse: pardon me while I rant a little about something that I’ve ranted about before. I refer to that disgrace to the medical profession, Dr. Mehmet Oz. I haven’t mentioned him on the site in a while, because really, why bother? Nothing that… Read More
  • Chemical News

    Ark Pharm’s Shady Side

    Once in a while we have discussions of chemical suppliers around here – but we haven’t had one like this. On Friday afternoon, word came out that Ark Pharm, a reasonably well-known firm out of Chicago, had been raided by the DEA. That becomes abundantly clear if you try to access the company’s web site. Read More
  • Infectious Diseases

    Fluoroquinolone Trouble Untangled

    The fluoroquinolone antibiotics are important drugs indeed – ciprofloxacin is probably the most famous of the bunch, but there’s a whole series of them, and they’re widely used for serious bacterial infections. (I last wrote about them here, with the various arguments about how they were developed in the first place). But for many… Read More
  • Business and Markets

    On Lies, and Liars

    ]\Today’s topic is “lies”. We will start with the cases of Elizabeth Holmes and Ramesh (“Sunny”) Balwani, of Theranos. As the world knows, Theranos was not what it was represented to be – John Carreyrou of the Wall Street Journal and his extraordinary demolition job on them showed that beyond doubt. But remember… Read More
  • Press Coverage

    Gotta Be a Conclusion In Here Somewhere

    A couple of years ago, I wrote about how far too much of human nutrition research was unfit to draw conclusions from. This new story does nothing to make a person more confident in the field: it’s a detailed look at the lab of Brian Wansink at Cornell, where he hold an endowed chair. He’s… Read More
  • The Dark Side

    Down the Rabbit Hole With Alireza Heidari

    Thanks to a comment on yesterday’s blog post, I was able to read this extraordinary tale, which comes to us courtesy of Prof. William Grover at UC Riverside’s Bioengineering department. Go check it out – you’ll learn of one Alireza Heidari, who is apparently quite the polymath. He is the author of 115 papers, which… Read More
  • Business and Markets

    Inside Scientific Information?

    Here’s a question that came up in the comments the other day, after I wrote about the recent publication suggesting possible immune-response problems with the Cas9 protein used in CRISPR. That paper sent the stocks of the major companies in the area down about 10% (well, mostly, and only after people had a weekend to… Read More
123...